MedTrace Logo

EAMA Sarcopenia in Acute Care Patients in 9+European Countries

NCT04039620 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 366

Last updated 2023-04-05

No results posted yet for this study

Summary

This collaborative study in 9 geriatrics units across Europe aims to apply emerging research to clinical practice, following the "Action-Research Philosophy" (11). The overall goal is to improve care in patients with - and help prevent - sarcopenia. Understanding the frequency of and risk factors for developing sarcopenia in an acute hospital setting, may help shed light on potential interventions and thus inform the development of future therapeutic strategies. It involves crucial implications for research, clinical practice, and policy towards optimal aging.

Conditions

Interventions

OTHER

Observational study, no interventions expected

No interventions are planned

Sponsors & Collaborators

  • Jagiellonian University

    collaborator OTHER

  • Université Libre de Bruxelles

    collaborator OTHER

  • Agaplesion Bethesda Clinic Ulm, Ulm, Germany

    collaborator UNKNOWN

  • Slagelse Hospital

    collaborator OTHER

  • Charles University, Czech Republic

    collaborator OTHER

  • NOVA Medical School

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Catholic University of the Sacred Heart

    collaborator OTHER

  • University Hospital, Ghent

    collaborator OTHER

  • University of Exeter

    collaborator OTHER

  • Parc de Salut Mar

    lead OTHER

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-06
Primary Completion
2021-04-02
Completion
2023-04-02

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04039620 on ClinicalTrials.gov